Invenomic Capital Management’s Teleflex TFX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-436,125
Closed -$52.2M 160
2026
Q1
$52.2M Buy
436,125
+89,566
+26% +$9.87M 2.39% 5
2025
Q4
$42.3M Sell
346,559
-39,113
-10% -$4.74M 1.97% 11
2025
Q3
$47.2M Buy
385,672
+101,287
+36% +$12.3M 2.28% 8
2025
Q2
$33.7M Sell
284,385
-60,347
-18% -$7.61M 1.91% 11
2025
Q1
$47.6M Buy
344,732
+321,751
+1,400% +$52.1M 2.41% 4
2024
Q4
$4.09M Buy
+22,981
New +$4.72M 0.19% 117

Other funds holding TFX

Invenomic Capital Management's TFX Position: Q2 2026 in Review

Invenomic Capital Management sold out of Teleflex (TFX) in Q2 2026, closing a stake of 436,125 shares — an estimated $52.2M sold.

Invenomic Capital Management first reported a position in TFX in Q4 2024 and held it in 6 quarters. The position peaked at $52.2M in Q1 2026. 383 funds tracked by Wall St. Rank hold TFX as of Q2 2026.

  • Invenomic Capital Management reported no remaining Teleflex position as of Q2 2026 after selling out during the quarter.
  • Invenomic Capital Management sold 436,125 Teleflex shares in Q2 2026, an estimated $52.2M.
  • Invenomic Capital Management first reported a position in Teleflex in Q4 2024 and held it in 6 quarters.
  • Invenomic Capital Management's Teleflex position peaked at $52.2M in Q1 2026.
  • 383 funds tracked by Wall St. Rank held Teleflex as of Q2 2026.

Based on Invenomic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.